NCT05010421View on ClinicalTrials.gov

Laser Vs Clobetasol for Lichen Sclerosus

PHASE3RecruitingINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

April 30, 2025

Study Completion Date

July 31, 2025

Conditions
Lichen Sclerosus
Interventions
DRUG

Clobetasol 0.05% Emollient Top Cream

Topical corticosteroid treatment of affected vulvar skin areas.

DEVICE

Non-ablative CO2 Laser

Superficial non-ablative laser treatment of affected vulvar skin areas.

Trial Locations (1)

44625

RECRUITING

Marien Hospital Herne, Herne

All Listed Sponsors
lead

Ruhr University of Bochum

OTHER